Sleep apnea treatment
Inspire is an FDA-approved obstructive sleep apnea (OSA) treatment option for people who cannot use Continuous Positive Airway Pressure (CPAP) therapy.
Inspire works inside the body with a patient's natural breathing process to treat sleep apnea. Mild stimulation opens the airway during sleep, allowing oxygen to flow naturally. The patient uses a small handheld remote to turn Inspire on before bed and off when they wake up.
The Inspire system is implanted during a short, outpatient procedure. The system is placed under the skin of the neck and chest through three small incisions. Most patients return home the same day and take over-the-counter pain medications to manage pain as needed.
Inspire is indicated for patients who are:
- Diagnosed with moderate to severe Obstructive Sleep Apnea
- Unable to use or get benefit from CPAP
- Not obese
- Age 18+
The safety and efficacy of Inspire was measured during the STAR clinical trial. One-year STAR trial results were published in January 9th, 2014 edition of the New England Journal of Medicine, showing patients using Inspire had significant reductions in sleep apnea events and significant improvements in quality of life measures. These significant reductions and improvements were sustained over a 5-year follow-up period. As of May 2020, there have been over 100 peer-reviewed publications on Inspire therapy.
